Latest News and Press Releases

– Late-breaking oral presentation of Phase 3 envudeucitinib data in moderate-to-severe plaque psoriasis (PsO) at the 2026 American Academy of Dermatology (AAD) Annual Meeting demonstrating early and...

– On track to report initial safety, PK and early activity from Phase 1 dose-escalation trial of STRO-004, potential best-in-class Tissue Factor ADC, in mid-2026 – – Continued advancement of...

FLOWER MOUND, Texas, May 14, 2026 (GLOBE NEWSWIRE) --  Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make...

VANCOUVER, British Columbia, May 14, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse...

First quarter 2026 revenue increased 9.6% year over year to $29.8 millionIncreased 2026 revenue guidance to $165–$170 million Wilmington, NC, May 14, 2026 (GLOBE NEWSWIRE) -- Off The Hook YS Inc....

Revenue of $4.3 million in Q1 2026, compared to $1.1 million in Q1 2025 on a comparable GAAP basisDelivered 21 vehicles in Q1 2026, compared to 5 vehicles in Q1 2025Announced 100-vehicle W56 purchase...

SARATOGA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy...

Q2 FY26 Marks Operational Inflection Point with Sequential 23% Revenue Growth and 44% Adjusted EBITDA Loss1 Improvement Strengthened Liquidity and Working Capital Position with Cash of $20.5 million...

REDWOOD CITY, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...

BioStem Technologies Reports First Quarter 2026 Financial Results